• Ownership

Phillip A. Sharp - Insider Trading & Ownership

Entity
Individual
Location
Biogen Inc Legal Department, 14 Cambridge Center, Cambridge, MA
Summary
The estimated net worth of Phillip A. Sharp is at least $73.7M dollars as of January 24, 2025. Phillip A. Sharp is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $73.4M. Phillip A. Sharp is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $272K.
All Insider Reports
All Insider Reports

Ownership of Phillip A. Sharp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. Director $73.4M -$3.09M -4.04% Jan 23, 2025
VIR Vir Biotechnology, Inc. Director $272K May 22, 2023
SYRS Syros Pharmaceuticals, Inc. Director Jun 1, 2022

Insider Transactions Reported by Phillip A. Sharp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.